Detected ·
RougeTx
$58M—
RougeTx, a Leiden University Medical Center spin-off, raised $58M in Series A financing co-led by Angelini Ventures, BGV (BioGeneration Ventures), and Kurma Partners to advance RTX-001 for hereditary hemorrhagic telangiectasia (HHT).
- Website
- rougetx.com
- linkedin.com/company/rougetx
- Amount
- $58 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-10-06 12:08:53 UTC
- Signal ID
- 8f307a8d-fa9e-4143-874f-582f51d34dcf
As the API returns it
{
"id": "8f307a8d-fa9e-4143-874f-582f51d34dcf",
"created_at": "2026-10-06T12:08:53.767166Z",
"company_name": "RougeTx",
"company_website_url": "rougetx.com",
"company_linkedin_url": "https://www.linkedin.com/company/rougetx",
"event_type": "funding",
"funding_amount": 58000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*RougeTx, a Leiden University Medical Center spin-off, raised $58M in Series A financing co-led by Angelini Ventures, BGV (BioGeneration Ventures), and Kurma Partners to advance RTX-001 for hereditary hemorrhagic telangiectasia (HHT).*"
}